Home DatasetsExperiment Details
E-GEOD-43021 GSE43021 transcription profiling by array Homo sapiens

Effect of ZFX shRNA mediated knockdown in the human AML cell line NOMO-1

·Released Jan. 1, 2015 ·Updated Feb. 11, 2015
4
Samples
4
Assays
1
Array Platforms
Description

Acute myeloid leukemia (AML) and acute T-lymphoblastic leukemia (T-ALL) maintain the undifferentiated phenotype and proliferative capacity of their respective cells of origin, hematopoietic stem/progenitor cells and immature thymocytes. The mechanisms that maintain these progenitor-like characteristics are poorly understood. We report that the transcription factor Zfx is required for the development and propagation of experimental AML caused by MLL-AF9 fusion, and of T-ALL caused by Notch1 activation. In both leukemia types, Zfx activated progenitor-associated gene expression programs and prevented differentiation. Key Zfx target genes included mitochondrial enzymes Ptpmt1 and Idh2, whose overexpression partially rescued the propagation of Zfx-deficient AML. These studies identify a common mechanism that controls the cell-of-origin characteristics of acute leukemias derived from disparate lineages and transformation mechanisms. NOMO-1 cells were infected with control and ZFX shRNA lentiviruses at an MOI of 1. RNA was collected for microarrays 48 hours after selection.

Array Platforms
A-AFFY-141
Affymetrix GeneChip Human Gene 1.0 ST Array [HuGene-1_0-st-v1](4 items)
Sample Attributes
cell line
NOMO-1
genotype
ZFX knock-down, ZFX wild type
organism
Homo sapiens
Experiment Info
Accession
E-GEOD-43021
GEO ID
GSE43021
Type
transcription profiling by array
Organism
Homo sapiens
Released
Jan. 1, 2015
Updated
Feb. 11, 2015
Submitter
Stuart P Weisberg、 Boris V Reizis、 Stuart Weisberg
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]